THG CEO granted additional RSUs as dividend equivalents
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group, Inc. reported that President and CEO John C. Roche received a grant of restricted stock units as part of his existing equity compensation. He was awarded 122.234 shares of common stock-equivalent RSUs under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs.
Following this award, Roche directly holds 141,132.982 shares of common stock. The filing notes that this figure does not include 14,454 additional shares held by his spouse. The newly granted RSUs will vest on the third anniversary of the original underlying RSU grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 122.234 | $0.00 | $0.00 |
Footnotes (2)
- F1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.
- F2. Does not include 14,454 shares held by the Reporting Person's spouse.
Key Figures
Key Terms
restricted stock units financial
dividend equivalent rights financial
2022 Long-Term Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did THG CEO John C. Roche report?
What is the nature of the RSU grant reported by THG’s CEO?
When will the newly granted THG RSUs to John C. Roche vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.